AIRE-MB

TOPIC 5: Clinical case

TOPIC 4: In patients in remission, when should we discontinue treatment?

TOPIC 3: In case of failure with anti-TNF, what treatment should we administer?

TOPIC 1: Inflammatory low back pain

Treatment

Introduction, clinical features, and classification criteria

TOPIC 3: Walking the tightrope: risk management in Rheumatoid Arthritis

TOPIC 2: Methotrexate, a guide for using it like a professional

TOPIC 1: What does seronegative Rheumatoid Arthritis hide?

Treatment recommendations for Rheumatoid Arthritis

Evaluation in Rheumatoid Arthritis

Diagnostic classification criteria

TOPIC 5: Drugs to consider

TOPIC 4: Management of liver disease

TOPIC 3: Management of patients with renal failure

TOPIC 2: Ultrasound imaging in Gout

TOPIC 1: Asymptomatic hyperuricemia: When to treat?

Gout

TOPIC 4: New treatments for thrombotic APS

TOPIC 3: Is the use of direct oral anticoagulants indicated in patients with APS?

TOPIC 2: In women with obstetric APS, what is the optimal management to prevent recurrences?

TOPIC 1: Interpret "non-criteria" antiphospholipid antibodies in patients clinically suspected APS

Antiphospholipid Syndrome

TOPIC 3: Role of repeat biopsy in Lupus Nephritis

TOPIC 2: Cytopenias in SLE: Disease flare or side effect?

Activity and damage indices in Systemic Lupus Erythematosus

Classification criteria for Systemic Lupus Erythematosus

TOPIC 4: Patient in remission: should biologic therapy be reduced or discontinued?

TOPIC 3: Patient profile for treatment with Apremilast

TOPIC 2: Patient profile for treatment with IL-17 inhibitors vs. IL-23 inhibitors vs. JAK inhibitors